Bajek David, Dawe Robert, Eadie Ewan, McGuire Victoria A, Ibbotson Sally
School of Medicine, University of Dundee, Dundee, UK.
Scottish Photobiology Service, Photobiology Unit, NHS Tayside, Ninewells Hospital, Dundee, UK.
Photodermatol Photoimmunol Photomed. 2025 Jul;41(4):e70034. doi: 10.1111/phpp.70034.
BACKGROUND/OBJECTIVES: Individuals with photosensitivity diseases, including porphyria, face significant challenges in managing their condition due to heightened sensitivity to ultraviolet (UV) and visible light. Comprehensive photoprotection strategies are essential and prioritize environmental modifications, behavioral adjustments, protective clothing, and hats. Sunscreens serve as a supplementary measure, particularly for exposed skin areas not otherwise protected. However, the extensive variety of available sunscreen products and limited guidance on their efficacy complicate the selection process. This study evaluates sunscreen use among photosensitive individuals and gathers feedback to inform future service development and research.
A questionnaire was completed by 32 individuals with porphyria (mostly with porphyrias causing skin photosensitivity) and 50 individuals with non-porphyric photosensitivity conditions, totaling 82 participants. The survey assessed preferences and experiences with sunscreens, focusing on criteria such as protection efficacy, cost, availability, and ease of use. Responses were analyzed to identify trends and challenges in integrating sunscreens into broader photoprotection strategies.
Protection efficacy was the primary factor influencing sunscreen choice among photosensitive patients, highlighting its importance alongside other photoprotection measures. The survey revealed considerable variation in sunscreen use. La Roche-Posay was the most favored brand. While 56% of porphyria patients used sunscreens explicitly labelled for visible light protection, only 11% of non-porphyric patients did so. Overall, 40% of participants reported issues with sunscreens, and approximately half expressed dissatisfaction with certain products, emphasizing the need for more effective and user-friendly options.
Sunscreens are a critical adjunct to broader photoprotection strategies for photosensitive patients but are not a standalone solution. Particularly for those with porphyrias, effectiveness was regarded as especially important. The variability in product preferences and the frequent difficulties reported highlight the need for improved guidance and accessibility of sunscreens tailored to diverse photosensitivity needs. Future research should focus on developing clear recommendations and expanding options to ensure effective and personalized photoprotection.
背景/目的:患有光敏感疾病(包括卟啉病)的个体,由于对紫外线(UV)和可见光的敏感性增强,在病情管理上面临重大挑战。全面的光保护策略至关重要,其中优先考虑环境改造、行为调整、防护服和帽子。防晒霜作为一种补充措施,尤其适用于未得到其他方式保护的暴露皮肤区域。然而,市面上防晒霜产品种类繁多,且关于其功效的指导有限,这使得选择过程变得复杂。本研究评估了光敏感个体使用防晒霜的情况,并收集反馈意见,以为未来的服务发展和研究提供参考。
32名患有卟啉病的个体(大多数患有导致皮肤光敏感的卟啉病)和50名患有非卟啉性光敏感疾病的个体填写了一份问卷,共有82名参与者。该调查评估了对防晒霜的偏好和使用体验,重点关注保护功效、成本、可获得性和易用性等标准。对回答进行分析,以确定将防晒霜纳入更广泛的光保护策略中的趋势和挑战。
保护功效是影响光敏感患者选择防晒霜的主要因素,突出了其与其他光保护措施同样重要的地位。调查显示防晒霜的使用存在很大差异。理肤泉是最受欢迎的品牌。虽然56%的卟啉病患者使用明确标注有可见光防护功能的防晒霜,但只有11%的非卟啉性患者这样做。总体而言,40%的参与者报告了使用防晒霜的问题,约一半的人对某些产品表示不满,这强调了需要更有效且用户友好的产品。
防晒霜是光敏感患者更广泛光保护策略的关键辅助手段,但不是唯一的解决方案。特别是对于那些患有卟啉病的人来说有效性被认为尤为重要。产品偏好的差异以及频繁报告的困难凸显了针对不同光敏感需求改进防晒霜指导和可及性的必要性。未来的研究应专注于制定明确的建议并扩大选择范围,以确保有效的个性化光保护。